Laboratorios Richmond Valuation
| RICH Stock | ARS 891.00 9.00 1.02% |
At this time, the firm appears to be overvalued. Laboratorios Richmond secures a last-minute Real Value of 775.21 per share. The latest price of the firm is 891.0. Our model forecasts the value of Laboratorios Richmond from analyzing the firm fundamentals such as Return On Equity of 0.22, profit margin of 0.11 %, and Current Valuation of 21.92 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend taking in undervalued stocks and trading overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Laboratorios Richmond's price fluctuation is very steady at this time. Calculation of the real value of Laboratorios Richmond is based on 3 months time horizon. Increasing Laboratorios Richmond's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Laboratorios Richmond SACIF is useful when determining the fair value of the Laboratorios stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Laboratorios Richmond. Since Laboratorios Richmond is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Laboratorios Stock. However, Laboratorios Richmond's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 891.0 | Real 775.21 | Hype 882.0 |
The real value of Laboratorios Stock, also known as its intrinsic value, is the underlying worth of Laboratorios Richmond Company, which is reflected in its stock price. It is based on Laboratorios Richmond's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Laboratorios Richmond's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Laboratorios Richmond's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Laboratorios Richmond SACIF helps investors to forecast how Laboratorios stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Laboratorios Richmond more accurately as focusing exclusively on Laboratorios Richmond's fundamentals will not take into account other important factors: Laboratorios Richmond Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Laboratorios Richmond's current stock value. Our valuation model uses many indicators to compare Laboratorios Richmond value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Laboratorios Richmond competition to find correlations between indicators driving Laboratorios Richmond's intrinsic value. More Info.Laboratorios Richmond SACIF is currently regarded as top stock in price to earning category among related companies. It is currently regarded as top stock in price to sales category among related companies . The ratio of Price To Earning to Price To Sales for Laboratorios Richmond SACIF is about 218.78 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Laboratorios Richmond by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Laboratorios Richmond's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Laboratorios Richmond's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Laboratorios Richmond's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Laboratorios Richmond and how it compares across the competition.
About Laboratorios Richmond Valuation
The stock valuation mechanism determines the current worth of Laboratorios Richmond SACIF on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Laboratorios Richmond SACIF. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Laboratorios Richmond based exclusively on its fundamental and basic technical indicators. By analyzing Laboratorios Richmond's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Laboratorios Richmond's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Laboratorios Richmond. We calculate exposure to Laboratorios Richmond's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Laboratorios Richmond's related companies.Laboratorios Richmond S.A.C.I.F. develops and manufactures pharmaceutical products for physicians, pharmacists, health institutions, and patients in Argentina and internationally. The company was founded in 1935 and is based in Buenos Aires, Argentina. LAB RICHMOND is traded on Buenos-Aires Stock Exchange in Argentina.
8 Steps to conduct Laboratorios Richmond's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Laboratorios Richmond's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Laboratorios Richmond's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Laboratorios Richmond's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Laboratorios Richmond's revenue streams: Identify Laboratorios Richmond's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Laboratorios Richmond's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Laboratorios Richmond's growth potential: Evaluate Laboratorios Richmond's management, business model, and growth potential.
- Determine Laboratorios Richmond's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Laboratorios Richmond's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Laboratorios Richmond SACIF. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Complementary Tools for Laboratorios Stock analysis
When running Laboratorios Richmond's price analysis, check to measure Laboratorios Richmond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratorios Richmond is operating at the current time. Most of Laboratorios Richmond's value examination focuses on studying past and present price action to predict the probability of Laboratorios Richmond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratorios Richmond's price. Additionally, you may evaluate how the addition of Laboratorios Richmond to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |